CoreWeave will rally more than 25% from here thanks to AI, says Cantor Fitzgerald

Cantor Fitzgerald initiated coverage on CoreWeave with an Overweight rating and a $116 price target, projecting 27% upside, citing the company's strong position as a key AI infrastructure hyperscaler. The firm highlights CoreWeave's focus on large language model training, its substantial $399 billion target market opportunity, and the strategic $9 billion acquisition of Core Scientific to expand critical power and data center capacity. CoreWeave's healthy access to capital markets further underpins its growth trajectory in the secular AI trend, with the stock already surging 128% since its March IPO.

Analysis

Cantor Fitzgerald has initiated coverage on CoreWeave (CRWV) with an Overweight rating and a $116 price target, implying a 27% potential upside. The firm's positive outlook is anchored in CoreWeave's strategic position as a specialized, software-driven AI hyperscaler, uniquely positioned to capitalize on secular growth trends in large language model (LLM) training and inference. The analysis highlights a substantial addressable market estimated at $399 billion and notes the company's impressive 38% compounded annual growth rate since 2023. A key near-term catalyst identified is the proposed $9 billion acquisition of Core Scientific (CORZ), which is expected to significantly expand CoreWeave's national data center footprint and, crucially, its access to power—a critical constraint in AI infrastructure deployment. Furthermore, the company's demonstrated ability to access capital markets, particularly debt, to fund its aggressive expansion is viewed as a significant strength, underpinning its growth trajectory. This positive assessment comes after the stock has already surged 128% since its March IPO, reflecting strong existing market conviction in its AI-centric strategy.

Key Decisions for Investors

• Investors should consider the bullish thesis from Cantor Fitzgerald, which projects 27% upside based on CoreWeave's position as a specialized AI hyperscaler within a $399 billion target market.
• Closely monitor the closing of the proposed $9 billion acquisition of Core Scientific (CORZ), as it is positioned as a primary near-term catalyst for expanding critical power and data center capacity.
• Given the stock's significant 128% appreciation since its March IPO, it is prudent to weigh the strong growth outlook against potential valuation sensitivity and the execution risks inherent in its capital-intensive expansion and M&A integration.